RIPK1 and chronic myelogenous leukemia, BCR-ABL1 positive: Notably, exposure to shikonin downregulates miR-92a-1-5p and induces necroptosis via activation of RIPK1/RIPK3/MLKL signaling in both TKI-sensitive and TKI-resistant CML cells.